Transcode Therapeutics Inc
NASDAQ:RNAZ
Balance Sheet
Balance Sheet Decomposition
Transcode Therapeutics Inc
Transcode Therapeutics Inc
Balance Sheet
Transcode Therapeutics Inc
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
21
|
5
|
3
|
6
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
1
|
21
|
5
|
3
|
6
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
2
|
2
|
1
|
|
| Total Current Assets |
0
|
0
|
1
|
23
|
7
|
4
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-5%
|
1
+417%
|
23
+2 074%
|
8
-67%
|
5
-32%
|
7
+41%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
0
|
3
|
3
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
3
|
4
|
3
|
3
|
|
| Long-Term Debt |
0
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
0
|
0
|
0
|
7
|
|
| Total Liabilities |
1
N/A
|
1
+83%
|
4
+240%
|
3
-43%
|
4
+72%
|
4
-19%
|
9
+164%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
1
|
3
|
10
|
28
|
46
|
63
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
31
|
31
|
48
|
61
|
|
| Total Equity |
1
N/A
|
1
-120%
|
3
-207%
|
20
N/A
|
3
-84%
|
2
-49%
|
2
N/A
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-5%
|
1
+417%
|
23
+2 074%
|
8
-67%
|
5
-32%
|
7
+41%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|